From the Division of Pediatric Gastroenterology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University, Palo Alto, CA.
Pancreas. 2021 Oct 1;50(9):1305-1309. doi: 10.1097/MPA.0000000000001923.
It is unknown to what extent coronavirus 2019 (COVID-19) may co-occur with acute pancreatitis (AP) in children and how their clinical course may differ from children with AP alone.
An online survey was sent to pediatric gastroenterologists to report on COVID-19 and AP cases from December 11, 2020, to February 26, 2021.
From 72 respondents (20 countries, 5 continents), 22 cases of positive COVID-19 infection and AP were reported. Patients were predominantly White or Hispanic/Latinx (73%), female (68%), and adolescents (68%). For 86% of patients, this was their first episode of AP. Sixty-eight percent of positive COVID-19 tests were polymerase chain reaction based. There was significant morbidity; 60% required intensive care, 45% had multiorgan involvement, and 24% developed shock. Eleven percent had pancreatic necrosis. Abnormal clotting and systemic inflammatory laboratories were common (31%-92% and 93%, respectively). Median length of symptomatic pancreatitis recovery was 1.8× longer than AP without COVID-19.
Coronavirus 2019 infection and AP co-occur primarily in children without a prior history of pancreatitis. Given the increased need for intensive care, multiorgan involvement, and potentially higher risk for pancreatic necrosis, pediatric providers should have a high level of suspicion for AP in children with COVID-19 infection.
目前尚不清楚 2019 年冠状病毒(COVID-19)在多大程度上可能与儿童急性胰腺炎(AP)同时发生,以及它们的临床过程与单独患有 AP 的儿童相比可能有何不同。
向儿科胃肠病学家发送了一份在线调查,以报告 2020 年 12 月 11 日至 2021 年 2 月 26 日期间的 COVID-19 和 AP 病例。
从 72 名应答者(20 个国家/地区,5 个大洲)中报告了 22 例 COVID-19 感染和 AP 阳性病例。患者主要为白种人或西班牙裔/拉丁裔(73%)、女性(68%)和青少年(68%)。对于 86%的患者,这是他们首次发作 AP。68%的 COVID-19 阳性检测是基于聚合酶链反应的。发病率很高;60%需要重症监护,45%有多个器官受累,24%发生休克。11%有胰腺坏死。异常凝血和全身性炎症实验室检查很常见(分别为 31%-92%和 93%)。有症状的胰腺炎恢复期中位数比没有 COVID-19 的 AP 长 1.8 倍。
COVID-19 感染和 AP 主要同时发生在没有胰腺炎既往史的儿童中。鉴于对重症监护、多器官受累和潜在更高的胰腺坏死风险的需求增加,儿科医生在 COVID-19 感染的儿童中应高度怀疑 AP。